These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11793027)

  • 1. Comment to: F. M. Nakhoul et al. (2001) Haptoglobin phenotype and diabetes. Diabetologia 44: 602-604.
    Moczulski DK; Rogus JJ; Krolewski AS
    Diabetologia; 2001 Dec; 44(12):2237-8. PubMed ID: 11793027
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment to: F. M. Nackhoul et al. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44: 602-604.
    Schaer DJ
    Diabetologia; 2001 Nov; 44(11):2104-5. PubMed ID: 11719844
    [No Abstract]   [Full Text] [Related]  

  • 3. Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.
    Levy AP
    Isr Med Assoc J; 2004 May; 6(5):308-10. PubMed ID: 15151377
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.
    Blum S; Milman U; Shapira C; Levy AP
    Pharmacogenomics; 2008 Aug; 9(8):989-91. PubMed ID: 18681772
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
    Levy AP; Gerstein HC; Miller-Lotan R; Ratner R; McQueen M; Lonn E; Pogue J
    Diabetes Care; 2004 Nov; 27(11):2767. PubMed ID: 15505023
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of haptoglobin genotype in adolescents with type 1 diabetes mellitus and endothelial function: an unresolved issue.
    Shechter M
    Isr Med Assoc J; 2007 Sep; 9(9):671-3. PubMed ID: 17939631
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
    Blum S; Vardi M; Levy NS; Miller-Lotan R; Levy AP
    Atherosclerosis; 2010 Jul; 211(1):25-7. PubMed ID: 20223458
    [No Abstract]   [Full Text] [Related]  

  • 8. Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes.
    Asleh R; Levy NS; Doros G; Costacou T; Robinson JG; Blum S; Goldenstein H; Boden WE; Simmons DL; Lacy MA; Grunberger G; Anderson TJ; Levy AP
    J Am Coll Cardiol; 2016 May; 67(21):2553-4. PubMed ID: 27230052
    [No Abstract]   [Full Text] [Related]  

  • 9. Haptoglobin genotype and its role in diabetic cardiovascular disease.
    Costacou T; Levy AP
    J Cardiovasc Transl Res; 2012 Aug; 5(4):423-35. PubMed ID: 22447230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The distribution of haptoglobin-phenotypes and haptoglobin-alleles in some diseases (Diabetes mellitus, liver parenchyma damage, psoriasis vulgaris)].
    Jörgensen G; Hopfer A
    Humangenetik; 1967; 3(4):277-81. PubMed ID: 6081910
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the Haptoglobin Genotype Be Considered in Setting Glycemic Goals for Diabetes Patients?
    Costacou T; Howard BV
    J Am Coll Cardiol; 2020 Feb; 75(5):522-524. PubMed ID: 32029135
    [No Abstract]   [Full Text] [Related]  

  • 12. [Haptoglobin polymorphism in patients with inflammatory bowel diseases].
    Papp M; Lakatos PL; ; Palatka K; Földi I; Udvardy M; Hársfalvi J; Tornai I; Vitális Z; Dinya T; Kovács A; Molnár T; Demeter P; Papp J; Lakatos L; Altorjay I
    Orv Hetil; 2006 Sep; 147(36):1745-50. PubMed ID: 17087019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic criteria of carbohydrate metabolism disorders in pulmonary tuberculosis complicated by diabetes mellitus in patients with various haptoglobin phenotypes].
    Parpieva NN; Kazakov KS
    Klin Lab Diagn; 2001 Feb; (2):10-2. PubMed ID: 11338533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic variants of haptoglobin in patients with nephrotuberculosis].
    Ubaĭdullaev AM; Kazakov KS; Khakimov MA
    Probl Tuberk; 2002; (7):42-3. PubMed ID: 12561643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of the haptoglobin phenotype in various neoplasms].
    Fonseca Sánchez E; Chimpen Ruiz V; López Berges C; Fermoso García J
    Med Clin (Barc); 1983 Sep; 81(7):321. PubMed ID: 6645677
    [No Abstract]   [Full Text] [Related]  

  • 16. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
    Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M
    Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haptoglobin types in peptic ulcer.
    Begum S; Habibullah CM; Ishaq M; Nayeem MA
    Trop Gastroenterol; 1988; 9(3):136-8. PubMed ID: 3194958
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of haptoglobin phenotype polymorphism in a Mennonite population of northern Mexico.
    Alvarado-Esquivel C; Delanghe J
    Rev Invest Clin; 2007; 59(6):491-2. PubMed ID: 18402342
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haptoglobin phenotype and risk of cervical neoplasia: a case-control study.
    Mahmud SM; Koushik A; Duarte-Franco E; Costa J; Fontes G; Bicho M; Coutlée F; Franco EL;
    Clin Chim Acta; 2007 Oct; 385(1-2):67-72. PubMed ID: 17706188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.